- Home
- TELA vs PMVP Comparison
TELA vs PMVP Comparison
Compare TELA & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- PMVP
- Stock Information
- Founded
- TELA 2012
- PMVP 2013
- Country
- TELA United States
- PMVP United States
- Employees
- TELA N/A
- PMVP N/A
- Industry
- TELA Medical/Dental Instruments
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- TELA Health Care
- PMVP Health Care
- Exchange
- TELA Nasdaq
- PMVP Nasdaq
- Market Cap
- TELA 70.1M
- PMVP 77.4M
- IPO Year
- TELA 2019
- PMVP 2020
- Fundamental
- Price
- TELA $1.62
- PMVP $1.40
- Analyst Decision
- TELA Buy
- PMVP Strong Buy
- Analyst Count
- TELA 3
- PMVP 1
- Target Price
- TELA $5.33
- PMVP $5.00
- AVG Volume (30 Days)
- TELA 106.3K
- PMVP 483.1K
- Earning Date
- TELA 11-06-2025
- PMVP 11-06-2025
- Dividend Yield
- TELA N/A
- PMVP N/A
- EPS Growth
- TELA N/A
- PMVP N/A
- EPS
- TELA N/A
- PMVP N/A
- Revenue
- TELA $75,323,000.00
- PMVP N/A
- Revenue This Year
- TELA $25.72
- PMVP N/A
- Revenue Next Year
- TELA $22.03
- PMVP N/A
- P/E Ratio
- TELA N/A
- PMVP N/A
- Revenue Growth
- TELA 16.34
- PMVP N/A
- 52 Week Low
- TELA $0.86
- PMVP $0.81
- 52 Week High
- TELA $3.26
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- TELA 44.30
- PMVP 46.72
- Support Level
- TELA $1.56
- PMVP $1.38
- Resistance Level
- TELA $1.87
- PMVP $1.59
- Average True Range (ATR)
- TELA 0.16
- PMVP 0.11
- MACD
- TELA -0.01
- PMVP -0.01
- Stochastic Oscillator
- TELA 18.00
- PMVP 20.00
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.